Literature DB >> 27718330

Risk Profile of Hepatitis E Virus from Pigs or Pork in Canada.

B Wilhelm1, A Fazil2, A Rajić1, A Houde3, S A McEwen1.   

Abstract

The role and importance of pigs and pork as sources of zoonotic hepatitis E virus (HEV) has been debated in Canada and abroad for over 20 years. To further investigate this question, we compiled data to populate a risk profile for HEV in pigs or pork in Canada. We organized the risk profile (RP) using the headings prescribed for a foodborne microbial risk assessment and used research synthesis methods and inputs wherever possible in populating the fields of this RP. A scoping review of potential public health risks of HEV, and two Canadian field surveys sampling finisher pigs, and retail pork chops and pork livers, provided inputs to inform this RP. We calculated summary estimates of prevalence using the Comprehensive Meta-analysis 3 software, employing the method of moments. Overall, we found the incidence of sporadic locally acquired hepatitis E in Canada, compiled from peer-reviewed literature or from diagnosis at the National Microbiology Laboratory to be low relative to other non-endemic countries. In contrast, we found the prevalence of detection of HEV RNA in pigs and retail pork livers, to be comparable to that reported in the USA and Europe. We drafted risk categories (high/medium/low) for acquiring clinical hepatitis E from exposure to pigs or pork in Canada and hypothesize that the proportion of the Canadian population at high risk from either exposure is relatively small.
© 2016 Crown copyright.

Entities:  

Keywords:  emerging diseases; veterinary epidemiology; zoonotic disease

Mesh:

Substances:

Year:  2016        PMID: 27718330     DOI: 10.1111/tbed.12582

Source DB:  PubMed          Journal:  Transbound Emerg Dis        ISSN: 1865-1674            Impact factor:   5.005


  9 in total

Review 1.  Hiding in Plain Sight? It's Time to Investigate Other Possible Transmission Routes for Hepatitis E Virus (HEV) in Developed Countries.

Authors:  Nicola J King; Joanne Hewitt; Anne-Marie Perchec-Merien
Journal:  Food Environ Virol       Date:  2018-04-05       Impact factor: 2.778

2.  Cross-sectional Seroprevalence and Genotype of Hepatitis E Virus in Humans and Swine in a High-density Pig-farming Area in Central China.

Authors:  Yilin Shu; Yameng Chen; Sheng Zhou; Shoude Zhang; Qin Wan; Changcai Zhu; Zhijiang Zhang; Hailong Wu; Jianbo Zhan; Ling Zhang
Journal:  Virol Sin       Date:  2019-07-01       Impact factor: 4.327

Review 3.  Swine hepatitis E virus: Cross-species infection, pork safety and chronic infection.

Authors:  Harini Sooryanarain; Xiang-Jin Meng
Journal:  Virus Res       Date:  2020-04-23       Impact factor: 3.303

4.  A qualitative program evaluation of the Publicly Available International Foodborne Outbreak Database.

Authors:  Abhinand Thaivalappil; Mariola Mascarenhas; Lisa A Waddell; Ian Young
Journal:  Can Commun Dis Rep       Date:  2021-01-29

Review 5.  Infection dynamics and persistence of hepatitis E virus on pig farms - a review.

Authors:  M Meester; T J Tobias; M Bouwknegt; N E Kusters; J A Stegeman; W H M van der Poel
Journal:  Porcine Health Manag       Date:  2021-02-05

6.  Bilateral neuralgic amyotrophy in a patient with livestock-associated hepatitis E virus infection.

Authors:  Nicholas J Miller; Davyd R Hooper; Aditya Sharma
Journal:  CMAJ       Date:  2022-04-04       Impact factor: 8.262

7. 

Authors:  Nicholas J Miller; Davyd R Hooper; Aditya Sharma
Journal:  CMAJ       Date:  2022-06-27       Impact factor: 16.859

Review 8.  Swine Norovirus: Past, Present, and Future.

Authors:  Lara Cavicchio; Andrea Laconi; Alessandra Piccirillo; Maria Serena Beato
Journal:  Viruses       Date:  2022-03-05       Impact factor: 5.048

9.  First molecular detection of hepatitis E virus genome in camel and pig faecal samples in Ethiopia.

Authors:  Fufa Dawo Bari; Haimanot Belete Wodaje; Umer Said; Hika Waktole; Melaku Sombo; Samson Leta; Tesfaye Rufael Chibsa; Paul Plummer
Journal:  Virol J       Date:  2021-08-04       Impact factor: 4.099

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.